Breaking News

FUJIFILM Diosynth Biotechnologies Invests £400M in UK Bio-Mfg. Site

Expansion will more than double the site’s development and manufacturing footprint and is expected to create as many as 350 highly-skilled jobs in Teesside.

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

FUJIFILM Diosynth Biotechnologies, a CDMO for biologics, viral vaccines and viral vectors, is investing £400 million at its UK facility in Billingham, Teesside. The investment will more than double the site’s existing development and manufacturing footprint, creating the largest multi-modal biopharmaceutical manufacturing site in the UK, and is expected to create up to 350 highly-skilled jobs. The new facilities are expected to be operational by late 2023.   The new multi-modal campus will inc...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters